Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Biocon Limited
Biocon Limited
Bristol-Myers Squibb
Qingdao Sino-Cell Biomedicine Co., Ltd.
Second Life Therapeutics
Onchilles Pharma Inc
AccSalus Biosciences, Inc.
OncoHost Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Oncodesign Precision Medicine
Rapa Therapeutics LLC
Xynomic Pharmaceuticals, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Power Life Sciences Inc.